Turning Science into Business: Commercialising CRISPR
Drug Discovery World
OCTOBER 24, 2023
While attending Life Science Baltics 2023, Diana Spencer spoke to Monika Paule , CEO and Co-founder of Caszyme, about creating a company based on CRISPR gene editing and some of the challenges of operating in this dynamic area of research. DS: What was the motivation for launching Caszyme and what challenges did you face creating a viable business?
Let's personalize your content